English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/129174
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Can coenzyme Q10 improve clinical and molecular parameters in fibromyalgia?

AuthorsCordero, Mario D. ; Alcocer-Gómez, Elísabet; Miguel, Manuel de; Carrión Rodríguez, Ángel Manuel ; Bullón, Pedro; Battino, Maurizio; Fernández-Rodríguez, Ana; Sánchez-Alcázar, José Antonio
Issue Date2013
PublisherMary Ann Liebert
CitationAntioxidants and Redox Signaling 19(12): 1356-1361 (2013)
AbstractFibromyalgia (FM) is a complex disorder that affects up to 5% of the general population worldwide. Its pathophysiological mechanisms are difficult to identify and current drug therapies demonstrate limited effectiveness. Both mitochondrial dysfunction and coenzyme Q10 (CoQ10) deficiency have been implicated in FM pathophysiology. We have investigated the effect of CoQ10 supplementation. We carried out a randomized, double-blind, placebo-controlled trial to evaluate clinical and gene expression effects of forty days of CoQ10 supplementation (300 mg/day) on 20 FM patients. This study was registered with controlled-trials.com (ISRCTN 21164124). An important clinical improvement was evident after CoQ10 versus placebo treatment showing a reduction of FIQ (p<0.001), and a most prominent reduction in pain (p<0.001), fatigue, and morning tiredness (p<0.01) subscales from FIQ. Furthermore, we observed an important reduction in the pain visual scale (p<0.01) and a reduction in tender points (p<0.01), including recovery of inflammation, antioxidant enzymes, mitochondrial biogenesis, and AMPK gene expression levels, associated with phosphorylation of the AMPK activity. These results lead to the hypothesis that CoQ10 have a potential therapeutic effect in FM, and indicate new potential molecular targets for the therapy of this disease. AMPK could be implicated in the pathophysiology of FM.
Publisher version (URL)http://dx.doi.org/10.1089/ars.2013.5260
URIhttp://hdl.handle.net/10261/129174
DOI10.1089/ars.2013.5260
ISSN1523-0864
E-ISSN1557-7716
Appears in Collections:(CABD) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.